CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Historical Holders from Q4 2015 to Q3 2025

Symbol
CTMX on Nasdaq
CUSIP
23284F105
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
166M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
137M
Holdings value
$438M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
101
Number of buys
59
Number of sells
-37
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 12.4% +34.4% $65.5M $16.3M 20.5M +33.3% FMR LLC Oct 31, 2025
Venrock Healthcare Capital Partners III, L.P. 9.4% +15% $49.6M $8.2M 15.6M +19.8% Venrock Healthcare Capital Partners III, L.P. Sep 30, 2025
Longitude Capital Partners V, LLC 7.3% $8.19M 11.5M Longitude Capital Partners V, LLC May 13, 2025
TANG CAPITAL MANAGEMENT LLC 7% -17.5% $27.4M $10.8M 11.1M +64.7% TANG CAPITAL MANAGEMENT, LLC Jun 30, 2025
PERCEPTIVE ADVISORS LLC 5.9% $22.5M 9.68M Perceptive Advisors LLC Aug 14, 2025
VANGUARD GROUP INC 5.95% $21.3M 9.38M The Vanguard Group Jun 30, 2025
ORBIMED ADVISORS LLC 5.4% $21M 8.46M OrbiMed Advisors LLC Jun 30, 2025
BIOTECHNOLOGY VALUE FUND L P 3.5% -47.1% $17.3M -$17.3M 5.77M -50% BVF PARTNERS L P/IL Jul 3, 2025
Point72 Asset Management, L.P. 2.5% -52% $13M -$12.8M 4.07M -49.7% Point72 Asset Management, L.P. Sep 30, 2025
Seven Fleet Partners LP 0.2% $268K 377K Seven Fleet Partners LP May 13, 2025
Seven Fleet Capital Management LP 0.02% $156K 48.9K Seven Fleet Master Fund LP Sep 30, 2025

Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 137M $438M +$24.4M $3.19 101
2025 Q2 133M $303M +$214M $2.27 82
2025 Q1 45.2M $28.7M -$1.51M $0.64 63
2024 Q4 46.7M $48.1M -$6.38M $1.03 68
2024 Q3 51.2M $60.4M +$481K $1.18 70
2024 Q2 50.7M $61.9M +$882K $1.22 73
2024 Q1 44.3M $96.6M +$25.5M $2.18 84
2023 Q4 32.6M $50.6M +$410K $1.55 66
2023 Q3 32.4M $41.8M -$2.42M $1.29 61
2023 Q2 34.1M $58.7M -$2.38M $1.72 66
2023 Q1 35.6M $53.8M -$933K $1.51 74
2022 Q4 36M $120M -$725K $1.60 77
2022 Q3 36.3M $52.6M -$19M $1.45 76
2022 Q2 45.6M $83.4M -$17.8M $1.83 86
2022 Q1 53.7M $143M -$1.75M $2.67 112
2021 Q4 54.3M $235M -$5.31M $4.33 106
2021 Q3 54M $275M -$17.3M $5.09 112
2021 Q2 56.7M $359M +$4.31M $6.33 119
2021 Q1 54.6M $422M +$130M $7.73 123
2020 Q4 38M $249M +$5.58M $6.55 123
2020 Q3 36.8M $245M -$11.6M $6.65 128
2020 Q2 37.8M $315M +$15.5M $8.33 133
2020 Q1 36.1M $277M +$245K $7.67 113
2019 Q4 36M $299M -$9.33M $8.31 119
2019 Q3 35.8M $264M -$1.38M $7.38 111
2019 Q2 35.6M $400M -$8.09M $11.22 108
2019 Q1 36.9M $397M -$12.8M $10.75 110
2018 Q4 37.8M $570M -$2.75M $15.10 109
2018 Q3 37.8M $697M +$95.6M $18.50 120
2018 Q2 32.3M $739M +$66.1M $22.86 140
2018 Q1 28.6M $814M +$73.3M $28.45 135
2017 Q4 30.1M $637M +$56M $21.11 119
2017 Q3 24.2M $441M +$42M $18.17 97
2017 Q2 22.1M $343M +$44.1M $15.50 89
2017 Q1 19.2M $332M +$58.3M $17.27 86
2016 Q4 16.9M $185M +$15M $10.99 68
2016 Q3 19.7M $243M +$18.1M $15.68 61
2016 Q2 18.8M $149M +$16M $10.21 59
2016 Q1 17.7M $228M +$3.39M $12.90 49
2015 Q4 12.5M $258M +$240M $20.87 47